Researchers discover unexpected role of mTORC2 protein in colorectal cancer
New results from researchers at MedUni Vienna's Center for Pathobiochemistry and Genetics show that a protein called mTORC2, which is the target of newly developed cancer drugs, is not even active in colorectal cancer. mTORC2 activity was only found in certain immune cells, which actually need this protein to fight cancer cells.
No hay comentarios:
Publicar un comentario